Cargando…

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis

The prognosis and treatment of the 2 main types of cardiac amyloidosis, immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, are substantially influenced by cardiac involvement. Cardiovascular magnetic resonance with late gadolinium enhancement (LGE) is a reference standard for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fontana, Marianna, Pica, Silvia, Reant, Patricia, Abdel-Gadir, Amna, Treibel, Thomas A., Banypersad, Sanjay M., Maestrini, Viviana, Barcella, William, Rosmini, Stefania, Bulluck, Heerajnarain, Sayed, Rabya H., Patel, Ketna, Mamhood, Shameem, Bucciarelli-Ducci, Chiara, Whelan, Carol J., Herrey, Anna S., Lachmann, Helen J., Wechalekar, Ashutosh D., Manisty, Charlotte H., Schelbert, Eric B., Kellman, Peter, Gillmore, Julian D., Hawkins, Philip N., Moon, James C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606985/ https://www.ncbi.nlm.nih.gov/pubmed/26362631 http://dx.doi.org/10.1161/CIRCULATIONAHA.115.016567

Ejemplares similares

LGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
por: Fontana, Marianna, et al.
Publicado: (2015)

Performance of automated ECV maps versus conventionally calculated ECV
por: Rosmini, Stefania, et al.
Publicado: (2015)

Native myocardial T1 and ECV with age and gender developing normal reference ranges - a 94 healthy volunteer study
por: Rosmini, Stefania, et al.
Publicado: (2016)

Hematocrit, iron and HDL-cholesterol explain 90% of variation in native blood T1
por: Rosmini, Stefania, et al.
Publicado: (2016)

Left ventricular remodeling after reperfused acute myocardial infarction: insights from automated ECV mapping
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

Chronic iron deposit and left ventricular remodeling in reperfused STEMI patients
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

Myocardial iron quantification using T2* and native T1mapping - a 250 patient study
por: Abdel-Gadir, Amna, et al.
Publicado: (2015)

Clinical application of MOLLI T1* for extracellular volume calculation in healthy volunteers and aortic stenosis
por: Bhuva, Anish N, et al.
Publicado: (2015)

Myocardial native T1 and extracellular volume with healthy ageing and gender
por: Rosmini, Stefania, et al.
Publicado: (2018)

Reproducibility of native T1 mapping using ShMOLLI and MOLLI - implications for sample size calculation
por: Bhuva, Anish N, et al.
Publicado: (2016)

Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post–Reperfused ST‐Elevation Myocardial Infarction
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

Redefining viability by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction
por: Bulluck, Heerajnarain, et al.
Publicado: (2017)

AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology
por: Fontana , Marianna, et al.
Publicado: (2014)

Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment–Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

An instantaneous ECV with no blood sampling: using native blood T1 for hematocrit is as good as standard ECV
por: Treibel, Thomas A, et al.
Publicado: (2015)

Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance
por: Bulluck, Heerajnarain, et al.
Publicado: (2017)

T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients
por: Bulluck, Heerajnarain, et al.
Publicado: (2015)

ECG, LVH and T1 changes in Fabry disease - implications for screening and understanding of the disease model
por: Kozor, Rebecca, et al.
Publicado: (2016)

CMR findings in high endurance veteran athletes - a 247 subject study
por: Maestrini, Viviana, et al.
Publicado: (2016)

Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study
por: Treibel, Thomas A, et al.
Publicado: (2016)

Diagnostic performance of T (1) and T (2) mapping to detect intramyocardial hemorrhage in reperfused ST‐segment elevation myocardial infarction (STEMI) patients
por: Bulluck, Heerajnarain, et al.
Publicado: (2017)

Quantification of the area-at-risk by T1 and T2 mapping CMR at 3T
por: Bulluck, Heerajnarain, et al.
Publicado: (2015)

Incidence of left ventricular thrombi in reperfused STEMI patients detected by contrast-enhanced CMR
por: Bulluck, Heerajnarain, et al.
Publicado: (2015)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

A simple technique to measure TAPSE and MAPSE on CMR and normal values
por: Bulluck, Heerajnarain, et al.
Publicado: (2014)

Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping
por: Bulluck, Heerajnarain, et al.
Publicado: (2017)

Precision and reproducibility of blood T1 estimation: implications of T1 star on ECV calculation
por: Bhuva, Anish N, et al.
Publicado: (2015)

The Right ventricle and cardiac surgery - more resilient than thought: multiparametric quantification shows altered rather than reduced function
por: Medina, Katia D Menacho, et al.
Publicado: (2016)

Cardiac amyloid burden assessment by T1 mapping predicts survival in patients with systemic AL amyloidosis - a 2 year follow-up study
por: Banypersad, Sanjay M, et al.
Publicado: (2014)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

T1 mapping in severe aortic stenosis: insights into LV remodeling
por: Treibel, Thomas A, et al.
Publicado: (2015)

OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis
por: Lane, T, et al.
Publicado: (2013)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

Precision measurement of cardiac structure and function in cardiovascular magnetic resonance using machine learning
por: Davies, Rhodri H., et al.
Publicado: (2022)

P910: DISPARATE PREDICTION OF OUTCOMES IN A UNIFORMLY TREATED COHORT OF PATIENTS WITH AL AMYLOIDOSIS STRATIFIED BY MAYO 2012 AND EUROPEAN CARDIAC STAGING SYSTEMS
por: Khwaja, Jahanzaib, et al.
Publicado: (2023)

Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance
por: Pica, Silvia, et al.
Publicado: (2014)

Occult senile cardiac amyloid in severe calcific aortic stenosis is not rare and has a poor prognosis: a 146 patient CMR biopsy study
por: Treibel, Thomas A, et al.
Publicado: (2016)

CMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015)

Extracellular volume quantification in isolated hypertension - changes at the detectable limits?
por: Treibel, Thomas A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4u0cf3l97a53r0q23dq6bj3l60